Skip to content

Investigation for the effects of Olive leaf on human health in cross-over study.

Investigation for the effects of Olive leaf on human health in cross-over study. - Investigation for the effects of Olive leaf on human health.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000034391
Enrollment
40
Registered
2019-03-31
Start date
2018-10-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Administration of test foods for 4 weeks. / Wash out for 4 weeks. / Administration of placebo foods for 4 weeks. Administration of placebo foods for 4 weeks. / Wash out for 4 weeks. / Administration

Sponsors

Miyake Medical Institute Group
Lead Sponsor
RIKEN Center for Biosystems Dynamics Research
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Healthy persons who are aged from 20 to 59 years.

Exclusion criteria

Exclusion criteria: 1.Persons who are in treatment. 2.Persons who have medical history of cardiovascular disease. 3.Persons who have dysfunction of autonomic nervous system. 4.Persons who have medical history of nervous system disease such as unconsciousness, coma, convulsion, etc. 5.Persons who have insomnia. 6.Persons who have food allergy. 7.Persons who are heavy user of alcohol. 8.Persons whose body mass index is less than 17 and more than 31. 9.Persons who are on a diet. 10.Pregnant women. 11.Persons who usually take in olive-related food. 12.Persons who have past or current medical history of serious disease such as diabetes mellitus, hepatic disease, kidney disease, cardiac disease, cholelithiasis, etc. 13.Persons who are now participating in other clinical trials, or participated in other clinical trials within a month before obtaining his/her informed consent in this trial. 14.Persons who are judged not suitable to participate in this trial by investigators.

Design outcomes

Primary

MeasureTime frame
Changes in oxidation stress and antioxidant activity after the administration for 4weeks

Secondary

MeasureTime frame
Subjective fatigue sensation

Countries

Japan

Contacts

Public ContactKei Mizuno

RIKEN Center for Biosystems Dynamics Research Laboratory for Pathophysiological and Health Science

keimizuno@riken.jp078-569-8868

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026